Actively Recruiting
Dopamine and Sensorimotor Function in Stuttering
Led by University of California, San Francisco · Updated on 2025-10-14
40
Participants Needed
1
Research Sites
39 weeks
Total Duration
On this page
Sponsors
U
University of California, San Francisco
Lead Sponsor
N
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.
CONDITIONS
Official Title
Dopamine and Sensorimotor Function in Stuttering
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Native speakers of American English
- Adults who stutter with onset before age 6 years
- Normal hearing
- Ages 18 to 65 years
- Healthy adults without hearing or language difficulties
You will not qualify if you...
- Speech, language, or hearing difficulties other than stuttering
- Neurological or psychological problems
- Use of medications affecting the dopaminergic system or benzodiazepines
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Biomagentic Imaging Lab
San Francisco, California, United States, 94143
Actively Recruiting
Research Team
N
Natalie Brunwin, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here